Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling

88Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

With aging, bone marrow mesenchymal stromal cell (MSC) osteoblast differentiation decreases whereas MSC differentiation into adipocytes increases, resulting in increased adipogenesis and bone loss. Here, we investigated whether activation of cell signaling by strontium ranelate (SrRan) can reverse the excessive adipogenic differentiation associated with aging. In murine MSC cultures, SrRan increased Runx2 expression and matrix mineralization and decreased PPARγ2 expression and adipogenesis. This effect was associated with increased expression of the Wnt noncanonical representative Wnt5a and adipogenic modulator Maf and was abrogated by Wnt- and nuclear factor of activated T-cells (NFAT)c antagonists, implying a role for Wnt and NFATc/Maf signaling in the switch in osteoblastogenesis to adipogenesis induced by SrRan. To confirm this finding, we investigated the effect of SrRan in SAMP6 senescent mice, which exhibit decreased osteoblastogenesis, increased adipogenesis, and osteopenia. SrRan administration at a clinically relevant dose level increased bone mineral density, bone volume, trabecular thickness and number, as shown by densitometric, microscanning, and histomorphometric analyses in long bones and vertebrae. This attenuation of bone loss was related to increased osteoblast surface and bone formation rate and decreased bone marrow adipocyte volume and size. The restoration of osteoblast and adipocyte balance induced by SrRan was linked to increased Wnt5a and Maf expression in the bone marrow. The results indicate that SrRan acts on lineage allocation of MSCs by antagonizing the age-related switch in osteoblast to adipocyte differentiation via mechanisms involving NFATc/Maf and Wnt signaling, resulting in increased bone formation and attenuation of bone loss in senescent osteopenic mice. © 2012 The Authors. Aging Cell © 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

References Powered by Scopus

Inhibition of adipogenesis by Wnt signaling

1648Citations
N/AReaders
Get full text

The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

1487Citations
N/AReaders
Get full text

PPARγ: A nuclear regulator of metabolism, differentiation, and cell growth

1113Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats

445Citations
N/AReaders
Get full text

Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics

341Citations
N/AReaders
Get full text

Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis

294Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Saidak, Z., Haÿ, E., Marty, C., Barbara, A., & Marie, P. J. (2012). Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling. Aging Cell, 11(3), 467–474. https://doi.org/10.1111/j.1474-9726.2012.00804.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 20

65%

Researcher 6

19%

Professor / Associate Prof. 4

13%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

37%

Agricultural and Biological Sciences 9

30%

Biochemistry, Genetics and Molecular Bi... 7

23%

Materials Science 3

10%

Save time finding and organizing research with Mendeley

Sign up for free